SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp.
GERN 1.310+0.8%Jan 16 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (53)8/15/1997 3:34:00 PM
From: Rob-Chemist   of 3578
 
Actually, cancer drugs are relatively small dollar value drugs. The reason for this is two-fold. First, cancer is really a variety of different diseases, such that a drug that works for cancer A will likely not work for cancer B. Second, when you treat a cancer patient, they are either cured or they die. Thus, your drug is limited in terms of the time for which it can be given. A much better cancer drug (at least from the companies perspective) would be one that controls the cancer without killing it. Then, you would be hooked on the drug until you die from something else. This latter reason is primarily why most cancer drugs have a max. market of low hundred million.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News